Fernando Pichel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fernando Pichel has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Clara Pinto
Serviço de Obstetrícia e Medicina Materno-Fetal, Unidade Local de Saúde de Santo António, 4050-366 Porto, Portugal
2 shared publications - Joana Vilaverde
Departamento de Endocrinologia, Centro Hospitalar Universitário de Santo António, Unidade Local de Saúde de Santo António, Porto, Portugal
2 shared publications - Jorge Dores
Transplant Department, Hospital Santo António, Porto, Portugal
2 shared publications - Ana Amado
Universitário do Porto, Porto, Portugal
1 shared publication - Ana Filipa Mendonça
Unidade Local de Saúde da Póvoa de Varzim/Vila do Conde EPE, Portugal
1 shared publication - Ana Rute Torrão Gomes
Unidade Local de Saúde da Póvoa de Varzim/Vila do Conde EPE, Portugal
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computing for Healthcare
Understanding the Self-monitoring Practices of People Living with Gestational Diabetes: A Qualitative Study with Implications for the Design of Self-monitoring Technologies
Gestational Diabetes (GD) is a common perinatal condition that can strongly impact the health of both the mother and the foetus. To avoid complications, people living with GD need to quickly learn to monitor their blood glucose levels and implement relevant changes to their diet and physical activity. Despite the importance of self-monitoring in GD, there is limited understanding of how people living with GD monitor their blood glucose in everyday life. This paper describes the self-monitoring practices of people living with GD in Portugal, drawing on 25 interviews with women who had GD, complemented by observations of glucose monitoring training sessions and interviews with five nurses. Our findings show that people living with GD learned complex practices within weeks of diagnosis, including measuring on the move, measuring while task-switching, and performing repeated measurements. We reflect on the impact of practices in everyday life and outline three implications for the design of self-monitoring technologies for GD.
- 1 July 2026
- Published by Association for Computing Machinery (ACM) in ACM Transactions on Computing for Healthcare
Open AccessUnderstanding the Self-monitoring Practices of People Living with Gestational Diabetes: A Qualitative Study with Implications for the Design of Self-monitoring Technologies
Gestational Diabetes (GD) is a common perinatal condition that can strongly impact the health of both the mother and the foetus. To avoid complications, people living with GD need to quickly learn to monitor their blood glucose levels and implement relevant changes to their diet and physical activity. Despite the importance of self-monitoring in GD, there is limited understanding of how people living with GD monitor their blood glucose in everyday life. This paper describes the self-monitoring practices of people living with GD in Portugal, drawing on 25 interviews with women who had GD, complemented by observations of glucose monitoring training sessions and interviews with five nurses. Our findings show that people living with GD learned complex practices within weeks of diagnosis, including measuring on the move, measuring while task-switching, and performing repeated measurements. We reflect on the impact of practices in everyday life and outline three implications for the design of self-monitoring technologies for GD.
- Open Access
Maternal Hypertriglyceridemia in Gestational Diabetes: A New Risk Factor?
Elevated maternal triglycerides (TGs) have been associated with excessive fetal growth. However, the role of maternal lipid profile is less studied in gestational diabetes mellitus (GDM). We aimed to study the association between maternal lipid profile in the third trimester and the risk for large-for-gestational-age (LGA) newborns in women with GDM. We performed an observational and retrospective study of pregnant women with GDM who underwent a lipid profile measurement during the third trimester. We applied a logistic regression model to assess predictors of LGA. A total of 100 singleton pregnant women with GDM and third-trimester lipid profile evaluation were included. In the multivariate analysis, pre-pregnancy BMI (OR 1.19 (95% CI 1.03–1.38), p = 0.022) and hypertriglyceridemia (OR 7.60 (1.70–34.10), p = 0.008) were independently associated with LGA. Third-trimester hypertriglyceridemia was found to be a predictor of LGA among women with GDM, independently of glycemic control, BMI, and pregnancy weight gain. Further investigation is needed to confirm the role of TGs in excessive fetal growth in GDM pregnancies.
Open AccessMaternal Hypertriglyceridemia in Gestational Diabetes: A New Risk Factor?
Elevated maternal triglycerides (TGs) have been associated with excessive fetal growth. However, the role of maternal lipid profile is less studied in gestational diabetes mellitus (GDM). We aimed to study the association between maternal lipid profile in the third trimester and the risk for large-for-gestational-age (LGA) newborns in women with GDM. We performed an observational and retrospective study of pregnant women with GDM who underwent a lipid profile measurement during the third trimester. We applied a logistic regression model to assess predictors of LGA. A total of 100 singleton pregnant women with GDM and third-trimester lipid profile evaluation were included. In the multivariate analysis, pre-pregnancy BMI (OR 1.19 (95% CI 1.03–1.38), p = 0.022) and hypertriglyceridemia (OR 7.60 (1.70–34.10), p = 0.008) were independently associated with LGA. Third-trimester hypertriglyceridemia was found to be a predictor of LGA among women with GDM, independently of glycemic control, BMI, and pregnancy weight gain. Further investigation is needed to confirm the role of TGs in excessive fetal growth in GDM pregnancies.
- Open Access
- 29 April 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (AHEAD) , 328-335
Third trimester HbA1c and the association with large-for-gestational-age neonates in women with gestational diabetes
Objective: To evaluate the association between HbA1c levels measured in the third trimester and the risk for large for gestational age (LGA) in neonates of mothers affected by gestational diabetes mellitus (GDM). Secondarily, we aimed to identify an ideal cut-off for increased risk of LGA amongst pregnant women with GDM. Materials and methods: Observational retrospective review of singleton pregnant women with GDM evaluated in a diabetes and pregnancy clinic of a tertiary and academic hospital. From January/2011 to December/2017, 1,085 pregnant women underwent evaluation due to GDM, of which 665 had an HbA1c test in the third trimester. A logistic regression model was performed to evaluate predictors of LGA. A receiver-operating-characteristic (ROC) curve was used to evaluate the predictive ability of third trimester HbA1c for LGA identification. Results: A total of 1,085 singleton pregnant women were evaluated during the study period, with a mean age of 32.9 +/- 5.3 years. In the multivariate analysis, OGTT at 0 minutes (OR: 1.040; CI 95% 1.006-1.076, p = 0.022) and third trimester HbA1c (OR: 4.680; CI 95% 1.210-18.107, p = 0.025) were associated with LGA newborns. Using a ROC curve to evaluate the predictive ability of third trimester HbA1c for LGA identification, the optimal HbA1c cut-off point was 5.4% where the sensitivity was 77.4% and the specificity was 71.7% (AUC 0.782; p < 0.001). Conclusions: Few studies in the Mediterranean population have evaluated the role of HbA1c in predicting neonatal complications in women with GDM. A third trimester HbA1c > 5.4% was found to have good sensitivity and specificity for identifying the risk of LGA.
- 29 April 2021
- Published by Archives of Endocrinology and Metabolism in Archives of Endocrinology and Metabolism
- Vol. 65 (AHEAD) , 328-335
Open AccessThird trimester HbA1c and the association with large-for-gestational-age neonates in women with gestational diabetes
Objective: To evaluate the association between HbA1c levels measured in the third trimester and the risk for large for gestational age (LGA) in neonates of mothers affected by gestational diabetes mellitus (GDM). Secondarily, we aimed to identify an ideal cut-off for increased risk of LGA amongst pregnant women with GDM. Materials and methods: Observational retrospective review of singleton pregnant women with GDM evaluated in a diabetes and pregnancy clinic of a tertiary and academic hospital. From January/2011 to December/2017, 1,085 pregnant women underwent evaluation due to GDM, of which 665 had an HbA1c test in the third trimester. A logistic regression model was performed to evaluate predictors of LGA. A receiver-operating-characteristic (ROC) curve was used to evaluate the predictive ability of third trimester HbA1c for LGA identification. Results: A total of 1,085 singleton pregnant women were evaluated during the study period, with a mean age of 32.9 +/- 5.3 years. In the multivariate analysis, OGTT at 0 minutes (OR: 1.040; CI 95% 1.006-1.076, p = 0.022) and third trimester HbA1c (OR: 4.680; CI 95% 1.210-18.107, p = 0.025) were associated with LGA newborns. Using a ROC curve to evaluate the predictive ability of third trimester HbA1c for LGA identification, the optimal HbA1c cut-off point was 5.4% where the sensitivity was 77.4% and the specificity was 71.7% (AUC 0.782; p < 0.001). Conclusions: Few studies in the Mediterranean population have evaluated the role of HbA1c in predicting neonatal complications in women with GDM. A third trimester HbA1c > 5.4% was found to have good sensitivity and specificity for identifying the risk of LGA.